Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Juno Therapeutics, Inc. market cap is N/A.
What is the 52-week high for Juno Therapeutics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Juno Therapeutics, Inc. 52 week high is N/A as of October 27, 2025.
What is the 52-week low for Juno Therapeutics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Juno Therapeutics, Inc. 52 week low is N/A as of October 27, 2025.
What is Juno Therapeutics, Inc. stock price today?
Juno Therapeutics, Inc. stock price today is $86.96.
What is the PE ratio of Juno Therapeutics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Juno Therapeutics, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Juno Therapeutics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Juno Therapeutics, Inc. P/B ratio is None.
What is Juno Therapeutics, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Juno Therapeutics, Inc.'s EBITDA is N/A.
What is the 50-day moving average of Juno Therapeutics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Juno Therapeutics, Inc. 50-day moving average is N/A.
How many employess does Juno Therapeutics, Inc. has?
